170 related articles for article (PubMed ID: 28189431)
1. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy.
Heckler M; Michalski CW; Schaefle S; Kaiser J; Büchler MW; Hackert T
Pancreatology; 2017; 17(2):255-262. PubMed ID: 28189431
[TBL] [Abstract][Full Text] [Related]
2. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
[TBL] [Abstract][Full Text] [Related]
3. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patients.
Hsiao CY; Yang CY; Wu JM; Kuo TC; Tien YW
Medicine (Baltimore); 2016 Sep; 95(38):e4922. PubMed ID: 27661043
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
6. The 2012 International Consensus Guidelines of Intraductal Papillary Mucinous Neoplasms of the Pancreas (Fukuoka Criteria) Predict the Malignant Potential, Even in Actual Clinical Situations.
Okamura Y; Sano S; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
Pancreas; 2018 Mar; 47(3):285-290. PubMed ID: 29401172
[TBL] [Abstract][Full Text] [Related]
7. Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.
Goh BK; Tan DM; Ho MM; Lim TK; Chung AY; Ooi LL
J Gastrointest Surg; 2014 Jul; 18(7):1350-7. PubMed ID: 24668367
[TBL] [Abstract][Full Text] [Related]
8. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC).
Duconseil P; Adham M; Sauvanet A; Autret A; Périnel J; Chiche L; Mabrut JY; Tuech JJ; Mariette C; Turrini O
Ann Surg Oncol; 2018 Apr; 25(4):1017-1025. PubMed ID: 29392508
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 2012 Fukuoka Consensus Guideline for Intraductal Papillary Mucinous Neoplasm of the Pancreas From a Single Institution Experience.
Yu S; Takasu N; Watanabe T; Fukumoto T; Okazaki S; Tezuka K; Sugawara S; Hirai I; Kimura W
Pancreas; 2017 Aug; 46(7):936-942. PubMed ID: 28697135
[TBL] [Abstract][Full Text] [Related]
10. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.
Jang JY; Park T; Lee S; Kang MJ; Lee SY; Lee KB; Chang YR; Kim SW
Br J Surg; 2014 May; 101(6):686-92. PubMed ID: 24668442
[TBL] [Abstract][Full Text] [Related]
11. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.
Pulvirenti A; Margonis GA; Morales-Oyarvide V; McIntyre CA; Lawrence SA; Goldman DA; Gonen M; Weiss MJ; Ferrone CR; He J; Brennan MF; Cameron JL; Lillemoe KD; Kingham TP; Balachandran V; Qadan M; D'Angelica MI; Jarnagin WR; Wolfgang CL; Castillo CF; Allen PJ
Ann Surg; 2021 Dec; 274(6):e980-e987. PubMed ID: 31804389
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
13. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms.
Zhou W; Xu Y; Rong Y; Wu W; Kuang T; Xin B; Zhu H; Lou W; Wang D
J Surg Oncol; 2018 Mar; 117(3):409-416. PubMed ID: 29044541
[TBL] [Abstract][Full Text] [Related]
14. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
15. [Surgical management of intraductal papillary mucinous neoplasms].
Jang JY
Korean J Gastroenterol; 2008 Oct; 52(4):220-5. PubMed ID: 19077523
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.
Goh BK; Lin Z; Tan DM; Thng CH; Khor CJ; Lim TK; Ooi LL; Chung AY
Surgery; 2015 Nov; 158(5):1192-202. PubMed ID: 26032832
[TBL] [Abstract][Full Text] [Related]
17. [Intraductal papillary mucinous neoplasm of the pancreas, IPMN].
Sirén J
Duodecim; 2013; 129(6):591-8. PubMed ID: 23614224
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
19. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
20. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
